The COURAGE Trial: Colon Recurrence and Aerobic Exercise: A Feasibility Study
The COURAGE Trial: Colon Recurrence and Aerobic Exercise: A Feasibility Study
Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of patients develop recurrent disease. Physical activity has emerged as a potential lifestyle intervention to reduce cancer recurrence and improve survival among people with colon cancer (CC). This pilot study aims to identify the dose-response effects of aerobic exercise on molecular and cellular pathways associated with physical activity and CC outcomes among patients with stage II and III CC.
Inclusion Criteria:
Exclusion Criteria:
history of another primary invasive cancer (other than non-melanoma skin-cancer);
evidence of metastatic CC (i.e., TNM M1);
planning to receive any additional adjuvant chemotherapy;
pregnant or breast feeding;
unable to provide baseline blood sample;
cardiac conditions, including the following:
any other condition that may impede testing of the study hypothesis or make it unsafe to engage in the exercise program (determined by the investigative team).